NVLN Novelion Therapeutics Inc.

$4.4 +1.62%

27,039 Shares Traded
51,259 Average Volume (last 30 days)

as of April 19, 2018 EST IEX Real-Time Price

Free Newsletter Sign Up

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $149.04 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-32.13%
If Intiated One Month Ago, Shorts Have Realized a Return of:-13.99%
If Initiated Five Days ago, Shorts Have Realized a Return of:-10.83%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 12.02%
Short Interest2.13 million
Float17.72 million
Short Ratio52.74
Market Cap$81.66 million
Market Maker ActivityDaily Short Volume


Midday Gainers / Losers (04/17/2018) (SeekingAlpha)
Novelion Therapeutics beats by $0.76, beats on revenue (SeekingAlpha)
Midday Gainers / Losers (SeekingAlpha)
Novelion Therapeutics reports Q3 results (SeekingAlpha)
Novelion unit Aegerion to admit guilt and pay $36M to settle Juxtapid case (SeekingAlpha)
Novelion Therapeutics fined over unit's misleading performance metric (SeekingAlpha)
Novelion Therapeutics' (NVLN) CEO Mary Szela on Q2 2017 Results - Earnings Call Transcript (SeekingAlpha)
Novelion Therapeutics EPS of -$1.15 (SeekingAlpha)
Notable earnings before Tuesday's open (SeekingAlpha)
Novelion Therapeutics' (NVLN) CEO Mary Szela on Q1 2017 Results - Earnings Call Transcript (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 93.9%
Insider Percent8.7%

Earnings Stats

PE Ratio -1.53
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $5.58
50 Day Moving Average $4.09
52 Week High $10.68
52 Week Low $3.08

Data provided for free by IEX. Questions? Read the FAQ